Description: Annuities are presenting ever-greater risks for the direct writers: • Variable annuities with guaranteed minimum and enhanced death benefits and income benefits • Fixed annuities with multi-year rate guarantees are capital intensive • In-force structured settlements have asset portfolios with declining investment yields • The impact to the payout annuity market from lengthening life expectancies From the Record of the Society of Actuaries, Volume 27, No. 3, Session 146 PD of the New Orleans Annual Meeting

Description: The use of longevity swaps are an area of growing interest in North America for insurers and pension schemes to manage their exposure to longevity risk. This growth is anticipated to continue as a consequence of the increased experience in the market and this maturity will encourage an improved affordability and ability for insurers to be flexible in this space. In Europe and Asia, longevity swaps are a much more established tool for risk transfer and optimizing asset-liability matching. From these markets, we can learn how to establish an effective framework in order to price, implement, and monitor performance of longevity swaps. By attending the session, you will be informed on the typical structure and modeling/valuation approach for longevity swaps including: - Understand longevity swap concepts, their benefits and common use. - Establish a basis for assessment such asmeasurement metrics, risk factors, and benchmarking principles. - Comprehend ongoing management such as basis risk, trigger points/pull-out clauses, potential operational issues, and asset transfer mechanisms. - Understand considerations and approach for valuing under US STAT and US GAAP.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Panel discusses securitization as a popular method for improving returns and clearing up balance sheets. From the Record of the Society of Actuaries, Vol. 23, No. 3., Session 74 PD of the Washington Annual Meeting

Description: From a session at a meeting of the Society of Actuaries held in San Diego, CA, June 22-23, 2000 A discussion of liquidity management for life insurance companies marketing institutional clients, in particular with respect to GIC contracts and Funding agreements. Topics included: · What happened at General American with their defaults on funding agreements. Why did the regulators and rating agencies miss the problems? · What was the impact of reinsurance? · What is the effect of adding institutional business such as putable funding agreements on liquidity management? · Are there prudent levels of this business that can be beneficial? · What is the effect of funding agreements with downgrade provisions on liquidity risks, and do such provisions create a preference for sophisticated institutional contract holders?

Description: In this webcast, presenters will outline the key content in ERM ASOPs 46, 47 and 55 and explore the impact each ASOP has on practitioners working in these fields. We will also describe the revision work currently under way in the ERM Committee of the Actuarial Standards Board.

Description: In light of recent regulatory developments and international best practices, the Bermuda Monetary Authority has introduced proposed enhancements to the Bermuda regulatory framework for long-term commercial insurers. During this panel discussion, discuss the potential impacts of these proposed regulatory changes for existing commercial insurers and new entrants to the Bermuda life reinsurance market.

Description: Participate in a discussion with panelists from various functional areas andcompanies about the trend of increasing mutual attractions between private equity and insurance companies, the underlying strategic drivers from both sides, as well as the impact to both individual insurance companies and insurance industry as a whole. Take part in a conversation about the implications of insurers' obligations/changes to risk profiles and exposures when engaging offshore domicile of affiliated and unaffiliated reinsurers involved in the private equity-owned insurance business.

Description: ClubVita Session Series Buyouts and indemnity swaps remove all the longevity risk from an underlying population. However, they can be difficult to unwind and are not very flexible or widely tradable. Explore the characteristics and product structures of indexed based longevity swaps, demonstrating how they can cover any term, how they hedge the key component of trend risk and how, with new technology developments, they could lead to a liquid market.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.